Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc.

<< Previous

Bullboard Posts

Next >>

Post by Oden6570on Jan 04, 2022 3:35am

440 Views

Post# 34280707

Interesting !

The novel nanodroplets have clear benefits for enhancing PDT efficacy by targeting hypoxic tumour regions. “These nanodroplets are made entirely from biocompatible and clinically-approved materials that could potentially enable its transition to the clinic,” says Mallidi

Oxygen-delivering nanodroplets enhance the efficacy of photodynamic therapy – Physics World

<< Previous

Bullboard Posts

Next >>

Eminent acquires promising Nevada gold project